يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"Christina Isakoglou"', وقت الاستعلام: 0.81s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    المساهمون: Donders Institute for Brain, Cognition and Behaviour, Radboud University [Nijmegen], Radboud University Medical Center [Nijmegen], Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University of Amsterdam [Amsterdam] (UvA), University of Mysore, Max Planck Institute for Biological Cybernetics, Max-Planck-Gesellschaft, Oxford Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB), University of Oxford [Oxford], Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institute of Psychiatry, Psychology & Neuroscience, King's College London, King‘s College London, University of Toronto, University of Cambridge [UK] (CAM), National Taiwan University [Taiwan] (NTU), Centre for Brain and Cognitive Development [Birkbeck College], Birkbeck College [University of London], Universität Heidelberg [Heidelberg], Medizinische Fakultät Mannheim, Goethe-University Frankfurt am Main, Génétique humaine et fonctions cognitives - Human Genetics and Cognitive Functions (GHFC (UMR_3571 / U-Pasteur_1)), Institut Pasteur [Paris]-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), This work has been primarily supported by the EU-AIMS (European Autism Interventions) program, which receives support from Innovative Medicines Initiative Joint Undertaking Grant No. 115300 and No. 777394, the resources of which are composed of financial contributions from the European Union’s Seventh Framework Program (Grant No. FP7/2007-2013), from the European Federation of Pharmaceutical Industries and Associations companies’ in-kind contributions. In addition, it has received funding from the AIMS-2-TRIALS program, which receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement No 777394. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA and AUTISM SPEAKS, Autistica and SFARI. Furthermore, this work was supported by the Niels Stensen Fellowship (to TW) and the Netherlands Organization for Scientific Research VIDI Grant Nos. 016.156.415 (to AFM) and 864.12.003 (to CFB)., European Project: 115300,EC:FP7:SP1-JTI,IMI-JU-03-2010,EU-AIMS(2012), Dumas, Guillaume, European Autism Interventions - A Multicentre Study for Developing New Medications - EU-AIMS - - EC:FP7:SP1-JTI2012-04-01 - 2017-03-31 - 115300 - VALID, University of Oxford, Institut Pasteur [Paris] (IP)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Radboud university [Nijmegen], Cognitive Science & AI, Crosscultural Psychology, TILT, Universität Heidelberg [Heidelberg] = Heidelberg University

    المصدر: Neuroscience and Biobehavioral Reviews
    Neuroscience and Biobehavioral Reviews, 2019, 104, pp.240-254. ⟨10.1016/j.neubiorev.2019.07.010⟩
    Wolfers, T, Floris, D L, Dinga, R, van Rooij, D, Isakoglou, C, Kia, S M, Zabihi, M, Llera, A, Chowdanayaka, R, Kumar, V J, Peng, H, Laidi, C, Batalle, D, Dimitrova, R, Charman, T, Loth, E, Lai, M-C, Jones, E, Baumeister, S, Moessnang, C, Banaschewski, T, Ecker, C, Dumas, G, O'Muircheartaigh, J, Murphy, D, Buitelaar, J K, Marquand, A F & Beckmann, C F 2019, ' From pattern classification to stratification: towards conceptualizing the heterogeneity of Autism Spectrum Disorder ', Neuroscience and biobehavioral reviews, vol. 104, pp. 240-254 . https://doi.org/10.1016/j.neubiorev.2019.07.010
    Neuroscience and Biobehavioral Reviews, 104, 240-254
    Neuroscience & Biobehavioral Reviews
    Neuroscience and Biobehavioral Reviews, 104, pp. 240-254
    Neuroscience and Biobehavioral Reviews, Elsevier, 2019, 104, pp.240-254. ⟨10.1016/j.neubiorev.2019.07.010⟩
    Neuroscience and Biobehavioral Reviews, 104, 240-254. Elsevier Limited

    وصف الملف: application/pdf